MaineHealth Maine Medical Center

Scarborough, ME
(888) 850-0650

Sorting 2 by

Not yet accepting

DREAMM-10

A Phase 3, Randomized, Open-label Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Learn more
  • Antibody Drug Conjugate (ADC)
  • BCMA
  • Phase 3

Accepting patients

Cancer Moonshot Biobank

Cancer Moonshot Biobank Research Protocol
Learn more